Skip to content
Peptides Codex

Use the arrow keys to choose a result, Enter to open it, and Escape to close.

← Home
Neuropeptide

Beta-endorphin

Beta-endorphin is a 31-amino-acid endogenous opioid peptide cleaved from the proopiomelanocortin (POMC) precursor. It is a foundational molecule in pain, stress, and reward neuroscience research.

By The Peptides Codex Editorial TeamIndividual review date not recorded

Page data last changed: . Registry refreshes and identity assessments are separate from scientific content review.

Reference backbone length
31 positions
Class
Neuropeptide
Function
Endogenous opioid signaling
Context
Pain, reward and stress neuroscience research

POMC-derived endogenous opioid beginning with the classic YGGFM motif.

Also known as: β-endorphin

Part of the Neuropeptides & signaling cluster

Overview

Beta-endorphin is a 31-amino-acid endogenous opioid peptide cleaved from the proopiomelanocortin (POMC) precursor. It is a foundational molecule in pain, stress, and reward neuroscience research.

Source & context

Biological / chemical source: Pituitary; derived from proopiomelanocortin (POMC)

Primary research or clinical context: Pain, reward and stress neuroscience research

From POMC precursor

Beta-endorphin is one of several peptides processed from POMC, alongside ACTH and MSH peptides. Its N-terminal Tyr-Gly-Gly-Phe-Met sequence is the same opioid motif found in met-enkephalin.

Receptor context

Beta-endorphin acts mainly at mu-opioid receptors within endogenous analgesia and reward circuits. Educational coverage here concerns this physiology and makes no claim about therapeutic use.

Sequence of the selected reference form

Sequence backbone for the reference form: Human beta-endorphin(1-31), unacetylated free-acid mature peptide. Termini, stereochemistry and modifications are described below.

YGGFMTSEKSQTPLVTLFKNAIIKNAYKKGE

YGGFMTSEKSQTPLVTLFKNAIIKNAYKKGE

Beta-endorphin31 aa · C158H251N39O46S · ≈ 3,465 Da · Free L-glutamate carboxylic acid (-COOH)PEPTIDESCODEX.COMN-terminus →→ C-terminusY1G2G3F4M5T6S7E−8K+9S10Q11T12P13L14V15T16L17F18K+19N20A21I22I23K+24N25A26Y27K+28K+29G30E−31nonpolarpolaracidicbasicGly / Pronon-canonical (X)Hydropathy (Kyte–Doolittle): ▮ hydrophobic (cyan) / ▮ hydrophilic (rose) · Side-chain charge at pH 7: + / −
Beta-endorphin — Structure cardDownload SVG
Y1G2G3F4M5T6S7E8K9S10Q11T12P13L14V15T16L17F18K19N20A21I22I23K24N25A26Y27K28K29G30E31
Helical wheel projection

Residues plotted ~100° apart around an α-helix — clustering of one color reveals an amphipathic face.

Analyze sequences in the playground →

Structure & chemistry

Molecular identity & reference confidence

Source-supported reference

Select the 31-residue unacetylated human beta-endorphin chain from reviewed human POMC. Its sequence and free-acid termini exactly match the independently inspected PubChem graph.

Molecular form
Human beta-endorphin(1-31), unacetylated free-acid mature peptide
Species
Homo sapiens
Termini (N / C)
Free alpha-amino group of L-tyrosine / Free L-glutamate carboxylic acid (-COOH)

Average reference mass · Molecular identity assessment: 2026-10-05

Reference policy updated: 2026-10-05

Molecular formula
C158H251N39O46S
Average reference mass
≈ 3,465
Backbone
Human beta-endorphin(1-31), unacetylated free-acid mature peptide
C-terminus
Free L-glutamate carboxylic acid (-COOH)
Identifiers

Chemistry values: curated profile, PubChem.

Clinical development snapshot

ClinicalTrials.gov lists 180 registered studies with “Beta-endorphin” as an intervention (snapshot 2026-10-01). A registry footprint is not evidence of efficacy or approval.

Registered studies
180
Highest phase reached
Phase 4
Active in latest 100
20
Most recent update
2026-09-22
Most recently updated studies
NCTTitlePhaseStatusUpdated
NCT07833163Corticotropin for Behçet's Disease: A Multicenter Randomized Controlled TrialAcronym.Phase 2not yet recruiting2026-09-22
NCT05907291Evaluate the Safety, Efficacy, and Pharmacokinetics of CRN04894 in Participants With Congenital Adrenal HyperpPhase 2completed2026-09-10
NCT01367964Prevention of West Syndrome With Low-dose Adrenocorticotropin Hormone (ACTH)Not applicableterminated2026-09-09
NCT07005154A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate CancerPhase 2recruiting2026-09-03
NCT02541955Use of Acthar in Rheumatoid Arthritis (RA) Related FlaresPhase 4completed2026-08-11
NCT02683889Use of Acthar in Patients With FSGS That Will be Undergoing Renal TransplantationPhase 3completed2026-07-01
See all on ClinicalTrials.gov →
Concentration math

Beta-endorphin — reconstitution calculator

Enter how much peptide is in the vial and how much diluent (e.g. bacteriostatic water) is added. The tool returns the resulting solution concentration — and, for any amount you type, the volume it corresponds to. This is educational arithmetic, not a dosing recommendation.

Reference form: Human beta-endorphin(1-31), unacetylated free-acid mature peptideAverage reference mass: 3,465 Da

Syringe graduation
Solution concentration
5 mg/mL5,000 mcg/mL
mcg

Enter an amount to see the volume it corresponds to.

Educational concentration mathematics only. This tool does not recommend a dose, amount, or protocol, and nothing here is medical advice. Many peptides are not authorized by Health Canada for human use — see our reconstitution and bacteriostatic-water guides for context.

Open the Beta-endorphin calculator on its own page →

Change log

Dated observations from the data pipeline (registry flags, trial footprints, identifiers) and editorial reviews of this profile.

  1. ChemistryPubChem formula updated to C158H251N39O46S.
  2. Trials1 registered study added on ClinicalTrials.gov (now 180).

FAQ about Beta-endorphin

What is Beta-endorphin?+

Beta-endorphin is a 31-amino-acid endogenous opioid peptide cleaved from the proopiomelanocortin (POMC) precursor. It is a foundational molecule in pain, stress, and reward neuroscience research.

What Canadian product status is recorded for Beta-endorphin?+

Canadian product status for Beta-endorphin has not been verified in this profile. No verified record here does not mean no authorization exists. Status depends on the product, formulation and use; consult Health Canada's product records.

What is the length of the selected reference form for Beta-endorphin?+

The selected reference form (Human beta-endorphin(1-31), unacetylated free-acid mature peptide) has 31 residues or residue-derived units in its backbone. Other forms in this family may have a different length.

Related peptides

References & further reading

  1. 1.Kato (1999). [Beta-endorphin]. Nihon Rinsho
  2. 2.Li (1982). beta-Endorphin. Cell
  3. 3.Okasha (1979). The brain's opium (human beta-endorphin). Egypt J Psychiatry
  4. 4.Kato (2005). [Beta-endorphin (beta-end)]. Nihon Rinsho
  5. 5.Heijnen et al. (1991). Beta-endorphin: cytokine and neuropeptide. Immunol Rev
  6. 6.Metzger et al. (1984). Beta-endorphin and sprint training. Life Sci
  7. 7.Foley et al. (1980). Intrathecal beta-endorphin. Lancet
  8. 8.Li (1979). Chemistry of beta-endorphin. Adv Biochem Psychopharmacol
  9. 9.PubChem — compound summary for beta-Endorphin (CID 16132316)
  10. 10.Wikipedia — Beta-endorphin
Disclaimer: Educational content only. Not medical advice. Not instructions for human use. Research peptides and unapproved products may be restricted or illegal to market for human consumption in your jurisdiction. Consult qualified professionals and applicable law.
You might also like: All peptides · Atlas · Research · Tools
Cite this: Peptides Codex — Beta-endorphin educational profile.
Tip: Use browser print (Ctrl/Cmd + P) for a clean PDF of this page.